Prevention and treatment of pain using antibodies to lysophosphatidic acid
US9274130B2 · kind B2 · utility
0Cited by
63References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2011 |
| Grant date | Mar 1, 2016 |
| Priority date | — |
| Expiry date | Jul 14, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for preventing or treating pain are provided. Such methods comprise administering to a subject (e.g., a human subject) an antibody or antibody fragment that binds LPA. The antibody may be a humanized monoclonal antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.